40 ára afmælisráðstefna SÁÁ: Treatment as prevention for hepatitis C (TraP HepC): A nationwide elimination program in Iceland Sigurður Ólafsson, MD, FACP, Director of Hepatology, Division of Gastroenterology, Department of Medicine Landspitali University Hospital Abstract Hepatitis C virus (HCV) infection is one of the leading causes of cirrhosis and hepatocellular carcinoma worldwide. Injection drug use is …Read more »
Erindi Ernu Milunka Kojic MD, professor at Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai A Structural Intervention to Improve Substance Abuse Diagnosis and Treatment Practices in HIV Clinic Settings. Treatment Adherence through the Advanced Use of Technology, preliminary findings
40 ára afmælisráðstefna SÁÁ: A Structural Intervention to Improve Substance Abuse Diagnosis and Treatment Practices in HIV Clinic Settings. Treatment Adherence through the Advanced Use of Technology, preliminary findings Judith A. Aberg, MD, FIDSA, FACP, Professor of Medicine, Chief, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai Abstract: Despite treatment advances in HIV with aggressive treatment …Read more »
Seminar: Viral infections and addiction, HIV and Hepatitis C Chair – Þórólfur Guðnason MD, PhD, Chief Epidemiologist, Centre for Health Security and Communicable Disease Control, Directorate of Health
40 ára afmælisráðstefna SÁÁ: New approaches to developing medications for helping smokers quit Frank J. Vocci, PhD, President, Friends Research Institute Abstract Tobacco smoking is the leading cause of preventable death in many developed countries. Nicotine replacement therapy (NRT) medications can double an individual’s chances of quitting but relapse is frequent. The majority of NRT …Read more »
Erindi Thorgeirs Thorgeirssonar, PhD, Decode Genetics Genes, brain and behavior. The Decode SÁÁ research collaboration: what have we learned?
40 ára afmælisráðstefna SÁÁ: Genes, brain and behavior. The Decode SÁÁ research collaboration: what have we learned? Kári Stefánsson, MD, Decode Genetics Kári Stefánsson, M.D., Dr. Med. has served as President, Chief Executive Officer and a Director since he founded deCODE genetics in August 1996. Dr. Stefánsson was appointed the Chairman of the Board of Directors …Read more »
Panel discussion: Cannabis Gerður Aaagot MD general practitioner, Rafn Magnús Jónsson, Project Manager at the Directorate of Health, politicians and policy makers and other interested parties.
Erindi Þórarins Tyrfingssonar MD, past Medical Director at SÁÁ Cannabis addiction in Iceland